Particle.news
Artificial Intelligence AI in Healthcare Robotic Surgery Medical Devices Diagnostic Tools Organ Transplantation AI in Medicine Brain Implants Surgical Procedures Surgical Systems Data Privacy Innovations in Healthcare Radiopharmaceuticals Radiology Extracorporeal Therapies ADHD Diagnosis AI Imaging Solutions Surgical Robotics Cardiovascular Devices Product Development Innovation MedTech Industry Robotics in Healthcare Innovative Diagnostics Corporate Strategy Cardiac Procedures Longevity Research Health Innovations Cardiovascular Health Health Sensors Health Informatics Mammograms Implantable Devices Venous Diseases Peripheral Vascular Devices MedTech Supply Chain Dependencies Regulation Brain-Computer Interfaces Augmented Reality AI Software Machine Learning Health Monitoring Artificial Intelligence in Healthcare Obstructive Sleep Apnea Innovations Rehabilitation Surgical Planning Health Apps Virtual Reality in Healthcare AR Headsets Biowearable Technology Blood Tests Cardiovascular Technology Glucose Monitoring Diagnostic Tests Cancer Treatment MRI Technology AI Voice Cloning Rare Earth Applications Data Integration Brain and Head Transplant Research Neuroscience Chat GPT Antimicrobial Paint Data Analysis Data Processing Artificial Organs Ultrasound Technology Genomic Testing Hologram Technology Telemedicine
The medical device maker adjusts its full-year EPS outlook and announces a $1 billion stock buyback, with shares rising over 6% in premarket trading.
